Using a blood test to find pancreatic cancer

This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.

This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.

This study is testing a new blood test that may help doctors find pancreatic cancer earlier. They want to see if this test works well by comparing results from people who have had the cancer or are at high risk.

This trial studies how well a new blood-based test may help find pancreatic cancer earlier. You may join if you’re an adult who fits a specific risk group and can safely provide a blood sample.

This study uses blood tests to look at how your immune system responds, to help find pancreatic cancer earlier. It compares people with pancreatic cancer, people with benign pancreatic conditions, and healthy people to improve diagnosis.

This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.